Skip to main content
. 2023 Mar 3;39(1):52–56. doi: 10.47717/turkjsurg.2023.5707

Table 2. Summary of diagnosis and treatment of nine advanced peritonitis cases.

Age (year) Symptom duration (day) WBC x109/L CRP mg/L SBO Radiologic evaluation Antibiotic course LOS day Complication
4 5 13.56 185.4 + US: Unvisualized appandix
CT: Appandix diameter 11.5 mm
Cefoperazone
Gentamicin metronidazole
9 θ
4 4 7.28 265.4 + CT: Appandix diameter 16.5 mm Ceftriaxone
Metronidazole
7 θ
4 4 20.64 98.6 + US-CT: Unvisualized appandix Ampicilline/Sulbactam
Gentamicin metronidazole
6 θ
7 7 22.00 32.5 + US: Unvisualized appandix Cefoperazone
Gentamicin metronidazole
8 θ
10 3 18.34 133.7 + US-CT: Unvisualized appandix Ampicilline/Sulbactam
Gentamicin metronidazole
6 θ
11 7 15.43 315.8 + US: Unvisualized appandix CT: Appandix diameter: 9 mm Meropenem
Ornidazole
15 θ
12 3 27.85 96.4 + US: Unvisualized appandix CT: Appandix diameter: 13 mm Ampicilline/Sulbactam
Gentamicin metronidazole
7 θ
16 5 17.82 371.1 + US: Appandix diameter:7 mm
CT: Appandix diameter:9 mm
Meropenem
Teikoplanin metronidazole
Fluconazole
10 θ
16 4 35.69 219.0 + US: Appandix diameter:5.7 mm
CT: Appandix diameter:13 mm
Cefoperazone
Gentamicin metronidazole
7 θ
LOS: Lenght of hospital stay, SBO: Small bowel obstruction, US: Ultrasonography, CT: Computed tomography.